Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026)

Phibro Animal Health's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $12.4 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 1.33% year-over-year to $12.4 million in Q1 2026; TTM through Mar 2026 was $50.6 million, a 19.31% increase from a year earlier, with the FY2025 full-year figure at $45.6 million, up 26.06% from the prior year.
• Depreciation & Amortization (CF) slipped to $12.4 million in Q1 2026 per PAHC's latest filing, from $12.9 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $12.9 million in Q4 2025 and bottomed at $8.4 million in Q2 2022.
• The 5-year median for Depreciation & Amortization (CF) is $9.0 million (2024), against an average of $10.0 million.
• Across the five-year window, Depreciation & Amortization (CF) soared 168900.0% in 2022 and decreased 1.33% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $8.5 million in 2022, then grew by 4.84% to $8.9 million in 2023, then rose by 29.9% to $11.6 million in 2024, then increased by 11.38% to $12.9 million in 2025, then fell by 3.44% to $12.4 million in 2026.
• Per Business Quant, the three latest PAHC Depreciation & Amortization (CF) figures stand at $12.4 million (Q1 2026), $12.9 million (Q4 2025), and $12.8 million (Q3 2025).